comparemela.com

Latest Breaking News On - Genmab - Page 1 : comparemela.com

Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript

Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript May 2, 2024 Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16. Genmab A/S isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to […]

Japan
Anthony-pagano
Anthony
Japan-new-drug-application
Genmab
Follicular-lymphoma
Anthony-mancini
Japan

Multispecific Antibodies Come to Grips with Manifold Targets

Multispecific Antibodies Come to Grips with Manifold Targets
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Mark-chiu
Randolf-kerschbaumer
Maria-macwilliams
Tavotek-biotherapeutics
Genmab
Christoph-rader
Raj-chopra
Esther-breij
Global-head-of-translational-research
Oncoone-technology
York-university-hattori

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Company Announcement COPENHAGEN, Denmark; February 23, 2024 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons. The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to publish trading in

Netherlands
Copenhagen
Køavn
Denmark
Valby
Hovedstaden
Japan
Tokyo
New-jersey
United-states
Marisol-peron
Anthony-pagano

Transactions in connection with share buy-back program

Company Announcement COPENHAGEN, Denmark; February 19, 2024 – Genmab A/S (Nasdaq: GMAB). On February 14, 2024, Genmab announced the initiation of a share buy-back program to honor our commitments under our Restricted Stock Units program. The share buy-back program is expected to be completed no later than March 15, 2024, and comprises up to 190,000 shares. The following transactions were executed under the program from February 15 to February 16, 2024: No. of sharesAverage price (DKK)Total value

New-jersey
United-states
Valby
Hovedstaden
Denmark
Japan
Netherlands
Copenhagen
Køavn
Tokyo
Andrew-carlsen
Marisol-peron

Notice to Convene the Annual General Meeting of Genmab A/S

Company Announcement Genmab A/S to hold Annual General Meeting on Wednesday March 13, 2024 COPENHAGEN, Denmark; February 15, 2024 – Genmab A/S (Nasdaq: GMAB) summons the Annual General Meeting on Wednesday, March 13, 2024, at 2:00 PM CET at the Copenhagen Marriott Hotel, Kalvebod Brygge 5, DK-1560 Copenhagen V, Denmark. The notice for the Annual General Meeting, including Appendix 1: Candidates for the Board of Directors, and Appendix 2: Proposed new Remuneration Policy is attached. About Genmab

Japan
Copenhagen
Køavn
Denmark
Netherlands
New-jersey
United-states
Valby
Hovedstaden
Tokyo
Marisol-peron
Andrew-carlsen

vimarsana © 2020. All Rights Reserved.